January 8, 2018 / 2:57 AM / Updated an hour ago

BRIEF-Guizhou Bailing Group Pharmaceutical signs technology development contract

Reuters Staff

1 Min Read

Jan 8(Reuters) - Guizhou Bailing Group Pharmaceutical Co Ltd :

* Says it signs technology development contract with Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine to develop diabetes capsule

Source text in Chinese: goo.gl/G2rF2F

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.